This review describes the history of
secretin discovery, identification, purification, and structural determination; cloning of
secretin and its
receptor; synthetic secretin; and highly specific and sensitive radioimmunoassay to define the characteristic physiological role on postprandial pancreatic fluid and
bicarbonate secretion, which requires robust potentiation by
cholecystokinin.
Secretin plays a key role in the negative and positive regulatory mechanisms of exocrine pancreatic secretion.
Secretin-releasing
peptides were discovered in duodenal
acid perfusates of both rat and dog and in canine pancreatic juice. The release and action of
secretin and
secretin-releasing
peptides are in part mediated via vagovagal reflex mechanism involving afferent sensory neurons in proximal intestine and efferent cholinergic neurons in the pancreas. Besides
acetylcholine, many
neurotransmitters or
neuromodulators influence release and action of
secretin. The action of
secretin in the pancreas depends on
insulin, which also suppresses local release of
somatostatin and
pancreatic polypeptide. Thus, release and action of
secretin are mediated via neurohormonal interaction. Clinical conditions with hypersecretinemia and hyposecretinemia are discussed. Synthetic human
secretin is used for studies of exocrine pancreatic secretion,
secretin-enhanced magnetic resonance cholangiopancreatography combined with exocrine pancreatic function test and diagnosis of
gastrinoma syndrome.
Therapeutic use of
secretin is considered for the relief of severe
pain in
chronic pancreatitis.